光威復材(300699.SZ):孫公司光威研究院引進新股東山東寬原
格隆匯 12 月 25日丨光威復材(300699.SZ)公佈,公司近日收到控股孫公司山東光威碳纖維產業技術研究院有限公司(“光威研究院”)的通知,光威研究院於近日進行了股權轉讓並完成工商變更登記。
近日,光威研究院引進新的股東山東寬原新材料科技有限公司(“山東寬原”),由股東威海光威精密機械有限公司將持有的光威研究院股份以100萬元的價格轉讓100萬股給山東寬原,佔光威研究院註冊資本的10%,並且已完成上述股權變更事項的工商變更登記手續。
山東寬原由山東大學、山東省碳纖維工程技術研究中心專家團隊創立,擁有技術人員20餘人,擁有發明專利14項,實用新型專利20餘項,建設有熱塑性碳纖維預浸織物及研發中心等項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.